Nippon Shinyaku
Nippon Shinyaku Head Office Exterior - Nishioji Street | |
| Company type | Public (K.K) |
|---|---|
| Industry | Pharmaceuticals, Functional Foods |
| Founded | October 1, 1919 in Kyoto, Japan |
| Headquarters | Kyoto [2][1][5] , Japan |
Area served | Worldwide |
Key people | Toru Nakai (President), Shigenobu Maekawa (Chairman), Takashi Takaya (Director), Kazuchika Takagaki (Director, Head R&D) [2][6][7][8] |
| Products | Prescription drugs, functional foods |
Number of employees | 2,243 (2025) |
| Website | www |
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology. Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy.